Showing results (191-200 of 294) with videos related to
Sort By:
Pageof 30
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|May 16, 2025
Insulin-like Growth Factor-1 Reflects Liver Disease Stage and Improves Prediction of Liver-related MortalityCarolin V Schneider, Stefan Gross, Sriram Balasubramani, et al.Hepatology (Baltimore, Md.)|January 24, 2003
Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver diseaseMatteo Vidali, Stephen F Stewart, Roberta Rolla, et al.Journal of Hepatology|December 16, 2022
NAFLD and NASH biomarker qualification in the LITMUS consortium - Lessons learnedDaniel Guldager Kring Rasmussen, Quentin M Anstee, Richard Torstenson, et al.Alimentary Pharmacology & Therapeutics|February 19, 2025
Addressing the High and Rising Global Burden of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH): From the Growing Prevalence to Payors' PerspectiveZobair M Younossi, Homie Razavi, Michael Sherman, et al.Gastroenterology|June 3, 2008
The Kruppel-like factor 6 genotype is associated with fibrosis in nonalcoholic fatty liver diseaseLuca Miele, Gary Beale, Gillian Patman, et al.Hepatology (Baltimore, Md.)|August 30, 2012
Validation of terminal peptide of procollagen III for the detection and assessment of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver diseaseSudeep Tanwar, Paul M Trembling, Indra N Guha, et al.Journal of Hepatology|February 26, 2017
Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLDPanu K Luukkonen, You Zhou, P A Nidhina Haridas, et al.BMC Cancer|August 7, 2009
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver diseaseJoe Gray, Dipankar Chattopadhyay, Gary S Beale, et al.Nature Reviews. Disease Primers|May 19, 2016
Nonalcoholic fatty liver diseaseElizabeth M Brunt, Vincent W-S Wong, Valerio Nobili, et al.Journal of Hepatology|December 23, 2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver diseaseOlivier Govaere, Sine Kragh Petersen, Nuria Martinez-Lopez, et al.Pageof 30